PRIMROSE BIO Patent: Single-Subunit RNA Polymerase Polynucleotide Synthesis
Summary
USPTO granted Patent US12600958B2 to PRIMROSE BIO, INC. on April 14, 2026. The patent covers compositions and methods for polynucleotide synthesis in vitro using single-subunit RNA polymerases. The application (No. 17614286, filed May 23, 2020) contains 9 claims under CPC classifications including C12N 9/1247 and C12P 19/34.
What changed
USPTO issued Patent US12600958B2 to PRIMROSE BIO, INC. for methods and compositions in polynucleotide manufacturing via single-subunit RNA polymerases. The patent covers in vitro RNA synthesis technology developed by five inventors including Dongxin Karen Xu and Helge Zieler.
Affected parties in the biotech and pharmaceutical RNA synthesis space should conduct freedom-to-operate analyses to assess whether PRIMROSE BIO's patent claims may affect their research, development, or manufacturing activities. Competitors developing similar RNA polymerase-based synthesis methods may need to consider licensing or design-around strategies.
What to do next
- Monitor patent portfolio for potential licensing opportunities
- Review patent claims for freedom-to-operate analysis
Archived snapshot
Apr 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Methods and compositions for manufacturing polynucleotides
Grant US12600958B2 Kind: B2 Apr 14, 2026
Assignee
PRIMROSE BIO, INC.
Inventors
Dongxin Karen Xu, Kadir Chir Tung, Sabrina Baffert, Alan Greener, Helge Zieler
Abstract
The present disclosure provides compositions and methods for polynucleotide synthesis in vitro, specifically the use of single-subunit RNA polymerases for synthesis and manufacturing of RNA.
CPC Classifications
C12N 15/63 C12N 9/1247 C12P 19/34 C12Q 1/6865 C12Q 2525/143 C12Q 2531/143 C12Y 207/07006
Filing Date
2020-05-23
Application No.
17614286
Claims
9
Named provisions
Related changes
Get daily alerts for USPTO Patent Grants - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.